Fibroblast-to-myofibroblast transition in bronchial asthma

M Michalik, K Wójcik-Pszczoła, M Paw, D Wnuk… - Cellular and Molecular …, 2018 - Springer
Bronchial asthma is a chronic inflammatory disease in which bronchial wall remodelling
plays a significant role. This phenomenon is related to enhanced proliferation of airway …

Allergic and nonallergic forms of atopic diseases

N Novak, T Bieber - Journal of Allergy and Clinical Immunology, 2003 - Elsevier
Atopic dermatitis, allergic rhinitis, and asthma are atopic diseases that develop on a complex
genetic background, the so-called atopic diathesis. Although they target different organs, in …

Current and future biomarkers in allergic asthma

UM Zissler, J Esser‐von Bieren, CA Jakwerth… - Allergy, 2016 - Wiley Online Library
Diagnosis early in life, sensitization, asthma endotypes, monitoring of disease and treatment
progression are key motivations for the exploration of biomarkers for allergic rhinitis and …

Structural basis of signaling blockade by anti-IL-13 antibody lebrikizumab

M Ultsch, J Bevers, G Nakamura, R Vandlen… - Journal of molecular …, 2013 - Elsevier
The cytokine interleukin 13 (IL-13) is a major effector molecule for T-helper type 2
inflammation and is pathogenic in allergic diseases such as asthma. The effects of IL-13 are …

Neuroimmunology of the Interleukins 13 and 4

S Mori, P Maher, B Conti - Brain sciences, 2016 - mdpi.com
The cytokines interleukin 13 and 4 share a common heterodimeric receptor and are
important modulators of peripheral allergic reactions. Produced primarily by T-helper type 2 …

Inhibition of human interleukin‐13‐induced respiratory and oesophageal inflammation by anti‐human‐interleukin‐13 antibody (CAT‐354)

C Blanchard, A Mishra, H Saito‐Akei… - Clinical & …, 2005 - Wiley Online Library
Background Allergic asthma is a complex disorder characterized by local and systemic T
helper type 2‐cell responses such as the production of IL‐13, a cytokine associated with the …

High serum levels of tumour necrosis factor‐α and interleukin‐8 in severe asthma: markers of systemic inflammation?

M Silvestri, M Bontempelli, M Giacomelli… - Clinical & …, 2006 - Wiley Online Library
Background Severe asthma is characterized by elevated levels of pro‐inflammatory
cytokines and neutrophilic inflammation in the airways. Blood cytokines, markers of …

STAT3 inhibition prevents lung inflammation, remodeling, and accumulation of Th2 and Th17 cells in a murine asthma model

AC Gavino, K Nahmod, U Bharadwaj, G Makedonas… - Allergy, 2016 - Wiley Online Library
Background STAT 3 drives development of Th17 cells and cytokine production by Th2 and
Th17 cells, which contribute to asthma. Alternative asthma treatments are needed …

Effects of omalizumab on markers of inflammation in patients with allergic asthma

S Holgate, N Smith, M Massanari, P Jimenez - Allergy, 2009 - Wiley Online Library
Asthma is a chronic inflammatory disease of the airways in which immunoglobulin E (IgE)
plays a key role by activating a variety of inflammatory cells through interactions with FcɛRI …

[HTML][HTML] How Do ROS Induce NETosis? Oxidative DNA Damage, DNA Repair, and Chromatin Decondensation

D Azzouz, N Palaniyar - Biomolecules, 2024 - mdpi.com
Neutrophil extracellular traps (NETs) are intricate, DNA-based, web-like structures adorned
with cytotoxic proteins. They play a crucial role in antimicrobial defense but are also …